{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:00:08Z","timestamp":1785481208436,"version":"3.56.0"},"reference-count":54,"publisher":"Baskent University","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.6002\/ect.2026.0042","type":"journal-issue","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:49:09Z","timestamp":1785412149000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"24","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Van Delden C, Stampf S, Hirsch HH, et al. Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss transplant cohort study. Clin Infect Dis. 2020;71(7):E159-E169. doi:10.1093\/cid\/ciz1113","DOI":"10.1093\/cid\/ciz1113"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Adelman MW, Connor AA, Hsu E, et al. Bloodstream infections after solid organ transplantation: clinical epidemiology and antimicrobial resistance (2016-21). JAC Antimicrob Resist. 2024;6(1):dlad158. doi:10.1093\/jacamr\/dlad158","DOI":"10.1093\/jacamr\/dlad158"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Carlos Jim\u00e9nez-Romero, Alberto Marcacuzco, Oscar Caso, et al. Long-term outcomes of liver transplant recipients. What do patients die from? World J Surg. 2025;49(6):1632-1642. doi:10.1002\/wjs.12614","DOI":"10.1002\/wjs.12614"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Zhong L, Men TY, Li H, et al. Multidrug-resistant gram-negative bacterial infections after liver transplantation - Spectrum and risk factors. J Infect. 2012;64(3):299-310. doi:10.1016\/j.jinf.2011.12.005","DOI":"10.1016\/j.jinf.2011.12.005"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Singh N, Gayowski T, Rihs JD, Wagener MM, Marino IR. Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transpl. 2001;7(1):22-26. doi:10.1053\/jlts.2001.20769","DOI":"10.1053\/jlts.2001.20769"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Gouv\u00eaa EF, Branco RC, Monteiro RC, et al. Outcome of infections caused by multiple drug-resistant bacteria in liver transplant recipients. Transplant Proc. 2004;4(36):958-960. doi:10.1016\/j.transproceed.2004.03.123","DOI":"10.1016\/j.transproceed.2004.03.123"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Kawecki D, Chmura A, Pacholczyk M, et al. Bacterial infections in the early period after liver transplantation: etiological agents and their susceptibility. Med Sci Monit. 2009;15(12):628-637.","DOI":"10.1016\/S1201-9712(08)60021-1"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Kim YJ, Yoon JH, Kim SI, et al. High mortality associated with Acinetobacter species infection in liver transplant patients. Transplant Proc. 2011;43(6):2397-2399. doi:10.1016\/j.transproceed.2011.06.011","DOI":"10.1016\/j.transproceed.2011.06.011"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Mohamed AA, Iman EK, Amin A, Samy S. Influence of multi drug resistance Gram negative bacteria in liver transplant recipient. Afr J Microbiol Res. 2013;7(41):4857-4861. doi:10.5897\/ajmr2013.5959","DOI":"10.5897\/AJMR2013.5959"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Gao F, Ye Q, Wan Q, Liu S, Zhou J. Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection. Ther Clin Risk Manag. 2015;11:501-505. doi:10.2147\/TCRM.S82251","DOI":"10.2147\/TCRM.S82251"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Singh A, Govil D, Baveja UK, et al. Epidemiological analysis of extended-spectrum beta-lactamase-producing bacterial infections in adult live donor liver transplant patients. Indian J Crit Care Med. 2018;22(4):290-296. doi:10.4103\/ijccm.IJCCM_206_17","DOI":"10.4103\/ijccm.IJCCM_206_17"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Cinar G, Kalkan \u0130A, Azap A, et al. Carbapenemase-producing bacterial infections in patients with liver transplant. Transplant Proc. 2019;51(7):2461-2465. doi:10.1016\/j.transproceed.2019.02.050","DOI":"10.1016\/j.transproceed.2019.02.050"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Liu N, Yang G, Dang Y, et al. Epidemic, risk factors of carbapenem-resistant Klebsiella pneumoniae infection and its effect on the early prognosis of liver transplantation. Front Cell Infect Microbiol. 2022;12:976408. doi:10.3389\/fcimb.2022.976408","DOI":"10.3389\/fcimb.2022.976408"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Wu X, Long G, Peng W, Wan Q. Drug resistance and risk factors for acquisition of gram-negative bacteria and carbapenem-resistant organisms among liver transplant recipients. Infect Dis Ther. 2022;11(4):1461-1477. doi:10.1007\/s40121-022-00649-1","DOI":"10.1007\/s40121-022-00649-1"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Verma A, Vimalesvaran S, Dhawan A. Epidemiology, risk factors and outcome due to multidrug resistant organisms in paediatric liver transplant patients in the era of antimicrobial stewardship and screening. Antibiotics. 2022;11(3):387. doi:10.3390\/antibiotics11030387","DOI":"10.3390\/antibiotics11030387"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Chiang D, Dingle TC, Belga S, et al. Association between gut colonization of vancomycin-resistant enterococci and liver transplant outcomes. Transpl Infect Dis. 2022;24(3):e13821. doi:10.1111\/tid.13821","DOI":"10.1111\/tid.13821"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Massa E, Michailidou E, Agapakis D, et al. Colonization and infection with extensively drug resistant gram-negative bacteria in liver transplant recipients. Transplant Proc. 2019;51(2):454-456. doi:10.1016\/j.transproceed.2019.01.076","DOI":"10.1016\/j.transproceed.2019.01.076"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. El-Badrawy MK, Ali RE, Yassen A, Elela MAA, Elmorsey RA. Early-onset pneumonia after liver transplant: microbial causes, risk factors, and outcomes, Mansoura University, Egypt, experience. Exp Clin Transplant. 2017;15(5):547-553. doi:10.6002\/ect.2016.0176","DOI":"10.6002\/ect.2016.0176"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Ziakas PD, Pliakos EE, Zervou FN, Knoll BM, Rice LB, Mylonakis E. MRSA and VRE colonization in solid organ transplantation: a meta-analysis of published studies. Am J Transplant. 2014;14(8):1887-1894. doi:10.1111\/ajt.12784","DOI":"10.1111\/ajt.12784"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Almohaya A, Fersovich J, Weyant RB, et al. The impact of colonization by multidrug resistant bacteria on graft survival, risk of infection, and mortality in recipients of solid organ transplant: systematic review and meta-analysis. Clin Microbiol Infect. 2024;30(10):1228-1243. doi:10.1016\/j.cmi.2024.03.036","DOI":"10.1016\/j.cmi.2024.03.036"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","unstructured":"22. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.","journal-title":"BMC Med Res Methodol"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"doi:10.1186\/1471-2288-5-13","DOI":"10.1186\/1471-2288-5-13"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"23. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135. doi:10.1186\/1471-2288-14-135","DOI":"10.1186\/1471-2288-14-135"},{"key":"ref24","unstructured":"24. Wells GA, Shea B, O'Connell Douglas, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. 2011. Accessed April 16, 2024. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"ref25","unstructured":"25. Higgins JP, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions. version 6.5. August 2024. Accessed January 6, 2026. www.cochrane.org\/handbook"},{"key":"ref26","unstructured":"26. Cochrane Collaboration. Review Manager: Systematic review and meta-analysis tool for researchers worldwide. RevMan Cochrane. 2024. Accessed February 6, 2026. https:\/\/revman.cochrane.org\/info"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"27. Ramakrishna JM, Khosla AA, Kr\u00f6ner PT, Brahmbhatt B, Stancampiano FF, Libertin CR. Prevalence, mortality, and resource utilization of Staphylococcus aureus bacteremia in liver transplant recipients: a 2012-2016 nationwide analysis. Clin Epidemiol Glob Health. 2022;16:101104. doi:10.1016\/j.cegh.2022.101104","DOI":"10.1016\/j.cegh.2022.101104"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"28. Logre E, Bert F, Khoy-Ear L, et al. Risk factors and impact of perioperative prophylaxis on the risk of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae-related infection among carriers following liver transplantation. Transplant. 2021;105(2):338-345. doi:10.1097\/TP.0000000000003231","DOI":"10.1097\/TP.0000000000003231"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"29. Santoro-Lopes G, Ferraz de Gouv\u00eaa \u00c9, Monteiro RC, et al. Colonization with methicillin-resistant Staphylococcus aureus after liver transplantation. Liver Transpl. 2005;11(2):203-209. doi:10.1002\/lt.20338","DOI":"10.1002\/lt.20338"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"30. Woeste G, Zapletal C, Wullstein C, Golling M, Bechstein WO. Influence of methicillin-resistant Staphylococcus aureus carrier status in liver transplant recipients. Transplant Proc. 2005;37(4):1710-1712. doi:10.1016\/j.transproceed.2005.03.136","DOI":"10.1016\/j.transproceed.2005.03.136"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"31. Hashimoto M, Sugawara Y, Tamura S, et al. Methicillin-resistant Staphylococcus aureus infection after living-donor liver transplantation in adults. Transpl Infect Dis. 2008;10(2):110-116. doi:10.1111\/j.1399-3062.2007.00253.x","DOI":"10.1111\/j.1399-3062.2007.00253.x"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"32. Singh N, Paterson DL, Chang Y, et al. Methicillin-resistant Staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients. Clin Infect Dis. 2000;30:322-329. doi:10.1086\/313658","DOI":"10.1086\/313658"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"33. Banach DB, Peaper DR, Fortune BE, Emre S, Dembry LM. The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients. Clin Transplant. 2016;30(3):306-311. doi:10.1111\/ctr.12690","DOI":"10.1111\/ctr.12690"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"34. Mouloudi E, Massa E, Papadopoulos S, et al. Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae among intensive care unit patients after orthotopic liver transplantation: risk factors for infection and impact of resistance on outcomes. Transplant Proc. 2014;46(9):3216-3218. doi:10.1016\/j.transproceed.2014.09.159","DOI":"10.1016\/j.transproceed.2014.09.159"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"35. Magro B, Mazzola A, Munteanu M, et al. Consequences of extended spectrum beta-lactamase-producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus carriage in awaiting liver transplant patients. Liver Transplant. 2021;27(1):43-54. doi:10.1002\/lt.25897","DOI":"10.1002\/lt.25897"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"36. Chen Y, Wang WL, Zhang W, et al. Risk factors and outcomes of carbapenem-resistant Enterobacteriaceae infection after liver transplantation: a retrospective study in a Chinese population. Infect Drug Resist. 2020;13:4039-4045. doi:10.2147\/IDR.S278084","DOI":"10.2147\/IDR.S278084"},{"key":"ref37","unstructured":"37. Shi SH, Kong HS, Jia CK, et al. Coagulase-negative staphylococcus and enterococcus as predominant pathogens in liver transplant recipients with Gram-positive coccal bacteremia. Chin Med J (Engl). 2010;123(15):1983-1988."},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"38. Chong PP, Koh AY. The gut microbiota in transplant patients. Blood Rev. 2020;39:100614. doi:10.1016\/J.BLRE.2019.100614","DOI":"10.1016\/j.blre.2019.100614"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"39. Mu J, Chen Q, Zhu L, et al. Influence of gut microbiota and intestinal barrier on enterogenic infection after liver transplantation. Curr Med Res Opin. 2019;35(2):241-248. doi:10.1080\/03007995.2018.1470085","DOI":"10.1080\/03007995.2018.1470085"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"40. Cervera C, van Delden C, Gavald\u00e0 J, Welte T, Akova M, Carratal\u00e0 J. Multidrug-resistant bacteria in solid organ transplant recipients. Clin Microbiol Infect. 2014;20(Suppl 7):49-73. doi:10.1111\/1469-0691.12687","DOI":"10.1111\/1469-0691.12687"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"41. Ikegami T, Shirabe K, Matono R, et al. Etiologies, risk factors, and outcomes of bacterial pneumonia after living donor liver transplantation. Liver Transplant. 2012;18(9):1060-1068. doi:10.1002\/lt.23483","DOI":"10.1002\/lt.23483"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"42. Hashimoto M, Sugawara Y, Tamura S, et al. Pseudomonas aeruginosa infection after living-donor liver transplantation in adults. Transpl Infect Dis. 2009;11(1):11-19. doi:10.1111\/j.1399-3062.2008.00341.x","DOI":"10.1111\/j.1399-3062.2008.00341.x"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"43. Shi SH, Kong HS, Jia CK, et al. Risk factors for pneumonia caused by multidrug-resistant Gram-negative bacilli among liver recipients. Clin Transplant. 2010;24(6):758-765. doi:10.1111\/j.1399-0012.2009.01184.x","DOI":"10.1111\/j.1399-0012.2009.01184.x"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"44. Pouladfar G, Jafarpour Z, Firoozifar M, et al. Urinary tract infections among hospitalized adults in the early post-liver transplant period: prevalence, risk factors, causative agents, and microbial susceptibility. Exp Clin Transplant. 2017;15(Suppl 1):190-193. doi:10.6002\/ect.mesot2016.P68","DOI":"10.6002\/ect.mesot2016.P68"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"45. Shepshelovich D, Tau N, Green H, et al. Immunosuppression reduction in liver and kidney transplant recipients with suspected bacterial infection: a multinational survey. Transpl Infect Dis. 2019;21(5):e13134. doi:10.1111\/TID.13134","DOI":"10.1111\/tid.13134"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"46. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195-283. doi:10.2146\/ajhp120568","DOI":"10.2146\/ajhp120568"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"47. Deinhardt-Emmer S, Chousterman BG, Schefold JC, et al. Sepsis in patients who are immunocompromised: diagnostic challenges and future therapies. Lancet Respir Med. 2025;13(7):623-637. doi:10.1016\/S2213-2600(25)00124-9","DOI":"10.1016\/S2213-2600(25)00124-9"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"48. Chen F, Pang XY, Shen C, et al. High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction. World J Gastroenterol. 2020;26(45):7191-7203. doi:10.3748\/wjg.v26.i45.7191","DOI":"10.3748\/wjg.v26.i45.7191"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"49. Sparkes T, Lemonovich TL; AST Infectious Diseases Community of Practice. Interactions between anti-infective agents and immunosuppressants: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13510. doi:10.1111\/CTR.13510","DOI":"10.1111\/ctr.13510"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"50. Thomas LD, Miller GG; AST Infectious Diseases Community of Practice. Interactions between antiinfective agents and immunosuppressants. Am J Transplant. 2009;9:S263-S266. doi:10.1111\/J.1600-6143.2009.02918.X","DOI":"10.1111\/j.1600-6143.2009.02918.x"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"51. Mathew JS, Philips CA. Drug interactions and safe prescription writing for liver transplant recipients. J Clin Exp Hepatol. 2023;13(5):869-877. doi:10.1016\/J.JCEH.2023.03.011","DOI":"10.1016\/j.jceh.2023.03.011"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"52. Campbell RE, Chen CH, Edelstein CL. Overview of antibiotic-induced nephrotoxicity. Kidney Int Rep. 2023;8(11):2211-2225. doi:10.1016\/j.ekir.2023.08.031","DOI":"10.1016\/j.ekir.2023.08.031"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"53. Naesens M, Kuypers DRJ, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4(2):481-508. doi:10.2215\/CJN.04800908","DOI":"10.2215\/CJN.04800908"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:37:48Z","timestamp":1785479868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/archive\/2026\/24\/6\/0\/470\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2026.0042","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}